Publication | Closed Access

Development of coumarin-thiosemicarbazone hybrids as aldose reductase inhibitors: Biological assays, molecular docking, simulation studies and ADME evaluation

Molecular DockingMedicinal ChemistryAdme EvaluationBioorganic ChemistryAldo-keto ReductaseBiochemistryMedicineNatural SciencesRational Drug DesignCoumarin-thiosemicarbazone HybridsPharmacotherapyDrug DevelopmentChemical BiologyPharmacologyDrug Discovery